Weight Loss Impact on Male Fertility
- Conditions
- Metabolic SyndromeObesitySub Fertility, Male
- Interventions
- Dietary Supplement: Very Low Carb Ketogenic Diet
- Registration Number
- NCT04186767
- Lead Sponsor
- University of Sao Paulo
- Brief Summary
This is a prospective non-randomized unicentric clinical trial, characterized by the inclusion of obese (BMI\> 35) male with subfertility (sperm count showing low sperm counts and / or motility and / or morphology and / or DNA fragmentation). Patients selected at the endocrinology obesity HC-FMUSP outpatient will be submitted to very low calorie diet (VLCK) for 6 months, being reassessed clinically and laboratorially monthly.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 20
Obesity in male patients
- Metabolic Syndrome (NCEP-ATP III)
- Alteration of some of the seminal parameters evaluated in conventional seminal analysis
-
Other causes of hypogonadotrophic hypogonadism
- Hypergonadotrophic hypogonadism
- Contraindications for performance of ketogenic diet:
- Type 1 or type 2 diabetes mellitus in insulin use
- Food drive
- Alcoholism or drug addiction
- Severe psychiatric illness
- Use of coumarin anticoagulants
- Hepatic insufficiency
- Severe renal impairment
- Hematologic diseases
- Cancer in activity,
- Cardiovascular or cerebrovascular diseases (arrhythmias, recent myocardial infarction, unstable angina, decompensated heart failure, recent stroke)
- Gout
- Renal or biliary lithiasis
- Major depression or other serious psychiatric illness.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Weight loss Very Low Carb Ketogenic Diet -
- Primary Outcome Measures
Name Time Method Seminal evaluation Six months DNA fragmentation will be combined to report
- Secondary Outcome Measures
Name Time Method Brow tissue study Six months Thermodynamic evaluation of brown adipose tissue using infrared thermography.
Adipose tissue toxins study Six months Persistent organic pollutants measure: 2,3,7,8- tetrachlorodibenzo-p-dioxin (TCDD)
Microbiota evaluation Six months Evaluate the whole intestinal metagenomics before and after the intervention
Body composition changes Six months Apply body composition digital analyser pre and post intervention.
Metabolic response Six months To evaluate the metabolic parameters lipid and glycemic profiles before and after intervention.
Inflamatory response Six months To evaluate cytokines TNFa and IL-6 response before and after intervention.
Epigenetic evaluation Six months To evaluate the epigenetic methylation profile of spermatozoa before and after the intervention
Hormonal measurements Six months To evaluate hormonal parameters total testosterone, LH, FSH, insulin before and after intervention.
Adipose tissue evaluation Six months To evaluate adipokines: leptin, adiponectin, UCP-1, FGF21, irisin and PGC1a measures before and after intervention.
Trial Locations
- Locations (1)
Hospital das Clinicas da Faculdade de Medicina da USP
🇧🇷São Paulo, Sao Paulo, Brazil